| |
| |
|
| Insider
Information: |
Quinn Anthony |
| Relationship: |
|
| City: |
Lexington |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
670,638 |
|
|
Indirect Shares
|
339,132 |
|
|
| Direct
Value |
$330,713 |
|
|
|
Indirect Value
|
$159,963 |
|
|
| Total
Shares |
1,009,770 |
|
|
| Total
Value |
$490,676 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
7
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
6
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -68.4%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Synageva BioPharma Corp |
GEVA |
EVP, CMO, & Head of R&D |
2015-06-22 |
0 |
|
0 |
Premium* |
|
|
Aeglea Biotherapeutics, Inc. |
AGLE |
President & CEO, Direc... |
2022-03-16 |
550,540 |
2022-03-16 |
266,295 |
Premium* |
|
|
Kaleido Biosciences, Inc. |
KLDO |
Director |
2019-03-04 |
31,603 |
|
0 |
Premium* |
|
|
Generation Bio Co. |
GBIO |
|
2023-12-01 |
88,495 |
2023-12-01 |
72,837 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
74 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GEVA |
Synageva BioPharma Corp |
SVP, Chief Medical OfficerOffi |
• – – |
2011-11-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
46,035 |
|
- |
|
| KLDO |
Kaleido Biosciences, Inc. |
Director |
– • – |
2019-02-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
18,750 |
|
- |
|
| GBIO |
Generation Bio Co. |
Director |
– • – |
2020-06-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
42,461 |
|
- |
|
| GEVA |
Synageva BioPharma Corp |
EVP, CMO, & Head of R&D |
• – – |
2015-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
27,000 |
32,637 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
EVP, CMO, & Head of R&D |
• – – |
2015-06-22 |
4 |
D |
$0.00 |
$0 |
D/D |
(32,675) |
0 |
0 |
- |
|
| KLDO |
Kaleido Biosciences, Inc. |
Director |
– • – |
2019-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
12,853 |
31,603 |
0 |
- |
|
| GBIO |
Generation Bio Co. |
Director |
– • – |
2020-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
30,376 |
72,837 |
0 |
- |
|
| GBIO |
Generation Bio Co. |
|
– • – |
2021-10-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
72,837 |
0 |
0 |
- |
|
| GBIO |
Generation Bio Co. |
|
– • – |
2021-10-28 |
4 |
GA |
$0.00 |
$0 |
I/I |
72,837 |
72,837 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
SVP, Chief Medical Officer |
• – – |
2012-07-19 |
4 |
OE |
$0.95 |
$1,805 |
D/D |
1,900 |
21,935 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
SVP, Chief Medical Officer |
• – – |
2012-07-20 |
4 |
OE |
$0.95 |
$570 |
D/D |
600 |
20,635 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
SVP, Chief Medical Officer |
• – – |
2012-07-26 |
4 |
OE |
$0.95 |
$1,045 |
D/D |
1,100 |
21,135 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
SVP, Chief Medical Officer |
• – – |
2012-07-27 |
4 |
OE |
$0.95 |
$6,080 |
D/D |
6,400 |
26,435 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
SVP, Chief Medical Officer |
• – – |
2013-01-16 |
4 |
OE |
$0.95 |
$335 |
D/D |
353 |
20,388 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
SVP, Chief Medical Officer |
• – – |
2013-01-17 |
4 |
OE |
$0.95 |
$190 |
D/D |
200 |
15,235 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
SVP, Chief Medical Officer |
• – – |
2013-01-18 |
4 |
OE |
$0.95 |
$8,975 |
D/D |
9,447 |
24,482 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
EVP, CMO & Head of R&D |
• – – |
2014-04-01 |
4 |
OE |
$0.95 |
$239,500 |
D/D |
20,000 |
35,524 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
EVP, CMO & Head of R&D |
• – – |
2014-04-01 |
4 |
OE |
$0.95 |
$9,500 |
D/D |
10,000 |
25,524 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
EVP, CMO & Head of R&D |
• – – |
2015-04-06 |
4 |
OE |
$0.95 |
$228,069 |
D/D |
19,503 |
45,140 |
0 |
- |
|
| GBIO |
Generation Bio Co. |
|
– • – |
2023-12-01 |
4 |
B |
$1.41 |
$124,778 |
D/D |
88,495 |
88,495 |
0.01 |
- |
|
| GEVA |
Synageva BioPharma Corp |
EVP, CMO & Head of R&D |
• – – |
2015-04-27 |
4 |
OE |
$1.70 |
$17,000 |
D/D |
10,000 |
15,637 |
0 |
- |
|
| AGLE |
Aeglea Biotherapeutics, I... |
President & CEO |
• • – |
2022-03-15 |
4 |
B |
$1.86 |
$78,942 |
D/D |
42,417 |
473,461 |
2.81 |
% |
|
| AGLE |
Aeglea Biotherapeutics, I... |
President & CEO |
• • – |
2022-03-14 |
4 |
B |
$1.93 |
$130,221 |
D/D |
67,472 |
431,044 |
2.81 |
% |
|
| AGLE |
Aeglea Biotherapeutics, I... |
President & CEO |
• • – |
2022-03-11 |
4 |
B |
$2.06 |
$71,780 |
D/D |
34,777 |
363,572 |
2.81 |
% |
|
| AGLE |
Aeglea Biotherapeutics, I... |
President & CEO |
• • – |
2022-03-16 |
4 |
B |
$2.34 |
$187,705 |
D/D |
80,079 |
550,540 |
2.81 |
% |
|
74 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
